The prototypical PKC ɛ BP agent “rescues” filopodia from promoter‐stimulated destruction, indicating that one mechanism is related to treatment with tumor promoter and therefore of signaling from phospholipase C. The second mechanism affects the steady‐state level of filopodia. The gene discussed is PRRT2; the disease is neoplasm.